Security key
92941V308
VYNE Therapeutics Inc. - common stock, par value $0.0001 (VYNE)
CUSIP: 92941V308
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / common stock, par value $0.0001
- Total 13F shares
- 7,312,555
- Total 13F value
- $14,256,902
- Share change
- -652,219
- SEC-reported price per share
- $1.88
- Number of holders
- 31
- Value change
- -$1,226,342
- Number of buys
- 5
- Number of sells
- 12
- Shares outstanding
- 33,403,382
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
31
Top holders
10
VYNE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V308
Recent filing periods:
Ownership snapshot
Top reported holders of VYNE - VYNE Therapeutics Inc. - common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EVENTIDE ASSET MANAGEMENT...
Disclosed value leader
EVENTIDE ASSET MANAGEMENT...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 4.2%
Showing 1-6 of 15 holder rows.
Quick read
EVENTIDE ASSET MANAGEMENT, LLC leads the comparable SEC ownership view at 4.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EVENTIDE ASSET MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
EVENTIDE ASSET MANAGEMENT, LLC
4.2%
Cormorant Asset Management, LP
4.2%
CITADEL ADVISORS LLC
3.6%
DSC Advisors, L.P.
2.1%
SILVERARC CAPITAL MANAGEMENT, LLC
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
4.2%
|
$3,130,284
1,394,336 shares
|
— | 30 Jun 2024 |
| Cormorant Asset Management, LP |
13F
Company
|
4.2%
|
$2,746,842
1,394,336 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
3.6%
|
$2,385,800
1,211,066 shares
|
— | 30 Jun 2024 |
| DSC Advisors, L.P. |
13F
Company
|
2.1%
|
$1,372,036
696,465 shares
|
— | 30 Jun 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$920,772
467,397 shares
|
— | 30 Jun 2024 |
| Palo Alto Investors LP |
13F
Company
|
1.3%
|
$877,505
445,434 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
7,312,555
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
30
Q3 2024 holders
31
Holder diff
1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend